1 / 36

Case presentation

Case presentation. 98/05/05 Presented by Intern : 吳勝騰. Patient profile. Name: 辜 O 雄 Chart number: 00555960 Age : 74-year-old Gender: male Date of admission: 98/4/23. Chief complaint. Fever up to 39’C with chills was noted in this morning.(4/23). Present illness.

jacqui
Télécharger la présentation

Case presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case presentation 98/05/05 Presented by Intern :吳勝騰

  2. Patient profile • Name:辜O雄 • Chart number: 00555960 • Age : 74-year-old • Gender: male • Date of admission: 98/4/23

  3. Chief complaint • Fever up to 39’C with chills was noted in this morning.(4/23)

  4. Present illness • This 74 y/o male is a case of • Diabetes mellitus was diagnosed 5 years ago, under oral anti-diabetic medication control. • Last month, he was admitted for jaundice. Decreased appetite and loss of body weight (2kg within 2 weeks ) were noted then. The patient also complained of tea colored urine and clay colored stool. • Associated symptoms and signs last month included: • fever (-), chills (-), fatigue(+) • mental disturbance or behavior change (-), general weakness (+), insomnia(-) • RUQ tenderness(-),hunger pain (-), post prandial pain (+), diarrhea (-), nausea (-), vomiting (-) ,tarry stool(-), bloody stool(-) • Yellowing of the skin(+), itching of the skin(+)

  5. Present illness • During last admission, a series of examinations were performed, and the laboratory data and image survey indicated the possibility of an obstructive leision involved his biliary tract. • Under the impression of obstructive jaundice, she received ERBD insertion on 4/9 for symptom relief.

  6. Clinical course Jaundice. Decreased appetite. Loss of body weight. Bil (T/D) =7.50/4.01 ALP = 1463 r-GT = 1504 WBC= 5290 CA199=180.65 4/09 Arrange ERCP , ERBD was inserted Unasyn 1 vial Q6H prophylatic for ascending cholangitis Arrange abdominal echo, Lipase=1837.9 Bil (T/D) =4.85/2.47 CRP = 6.4 4/10 4/12 Fever up to 39.1, B/C x 2 , Arrange MRCP Unasyn used day 5 4/14 4/16 Discharged form our ward.

  7. Present illness • However, after discharged from our ward, fever up to 39’C attacked him again with chills on 4/23, and his family brought him to our ER for help. • Associated symptoms and signs included: • fever & chills(+), weakness (+), fatigue(+), rhinorrhea(-), sore throat(-), nasal obstruction(-), intermittent cough with mild sputum(-), • abdominal pain(-), nausea(-), vomiting(-) ,bowel habit change(-), pain, tarry stool(-), bloody stool(-), clay color stool(-) • urinary frequecny(-), burnning sensation(-), dysurea(-) • Yellowing of the skin(-), itching of the skin(-)

  8. Clinical course • Under the impression of recurrent biliary tract infective episode, he was admitted again, and received antibiotic therapy.

  9. Past history • Diabetic mellitus: diagnosed 5 years ago, under oral anti-diabetic medication control (Diamicron 1# bid AC). • Hypertensionwith medication control since 民國 94 年 • Olmetec 0.5# OM, Capoten 1# PRN • Hepatitis non B, non C diagnosed on 民國92年 • HBV/HCV: HBsAg(-), Anti-HCV(-) (92.09.12) • Alcohol/Smoking(+/+): now quit for 20 yrs • Duodenal ulcer history(+) • Gouty arthritis: diagnosed on 民國88年 • Hyperlipidemia (+) • Operation history: denied • Allergy history: pyrine

  10. Family history Not contributory

  11. Current medicine • Diamicron MR(●) ﹝1 * BID AC * 28 D﹞ • Olmetec ﹝0.5 * OM * 28 D﹞ • Strocain(息痛佳音錠) ﹝1 * TID PC * 14 D﹞ • Nidolium ﹝1 * TID PC * 14 D﹞ • Suwell ﹝1 * TID PC * 14 D﹞ • Denied of Chinese herb use , medication for gouty atritis, and other drug exposure.

  12. Physical examination on ER (4/23) • Vital sign: BP: 100/55 mmHg, PR: 94 bpm, RR: 22 cpm, BT: 39.1 ℃ • General Appearance: Consciousness: alert (E4V5M6) • Conjunctivae: not pale ; Sclera: not icteric • Neck:Supple, no palpable mass • no jugular vein engorgement • no goiter • No lymphadenopathy

  13. Physical examination (4/23) • Chest:Symmetric expansion • BS: clear, no wheezing or crackles • Heart:Regular heart beats without audible murmur • Abdomen: • Inspection : mild distended • Palpation • Soft, Tender (+) RUQ, Guarding(-), Rebounding pain (+/-) • Liver / Spleen: -/- • Percussion : tympanic(-), Shifting dullness(-) Auscultation : Normoactive bowel sound • Extremities and skin: • Pitting edema (-) • Freely movable

  14. Lab data on 4/23 (ER)

  15. Lab data on 4/23 (ER)

  16. Urine routine examination

  17. Stool routine examination

  18. Tentative diagnosis on 4/23 • Suspect recurrent biliary tract infection • Obstructive Jaundice post endoscopic retrograde biliary drainage (98.4.9) , • Suspect early stage of ampulla vater tumor. • Diabestes mellitus, type 2 • Hypertension • Hepatitis

  19. Clinical course • Under the impression of recurrent biliary tract infective episode, he was admitted again, and received antibiotic therapy. • We arranged abdominal echo on 4/25 in comparison of prior image on 4/10. • For his condition is stable, and meet the indication of biliary surgery, he was discharged and went to KHCG for surgical intervention.

  20. Hyperbilirubinemia

  21. Hyperbilirubinemia • The presence of scleral icterus indicates a serum bilirubin of at least 51 mol/L (3.0 mg/dL). • The bilirubin present in serum represents a balance between input from production of bilirubin and hepatic/biliary removal of the pigment. Hyperbilirubinemia may result from • (1) overproduction of bilirubin • (2) impaired uptake, conjugation, or excretion of bilirubin • (3) regurgitation of unconjugated or conjugated bilirubin from damaged hepatocytes or bile ducts.

  22. Bilirubin metabolism

  23. Thank you very much!

  24. Lab data on 4/9

  25. Lab data on 4/9

  26. Blood culture on 4/12

More Related